R

Rallybio Corp
D

RLYB

0.33840
USD
-0.03
(-8.47%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
14,082,165
أصول ذات صلة
APD
APD
-3.35
(-1.19%)
277.09 USD
AVY
AVY
-2.518
(-1.43%)
173.910 USD
DOW
DOW
-1.135
(-3.71%)
29.430 USD
E
EMN
-1.865
(-2.42%)
75.165 USD
IP
IP
-0.655
(-1.41%)
45.920 USD
LYB
LYB
-1.615
(-2.64%)
59.595 USD
NUE
NUE
0.650
(0.53%)
122.300 USD
PPG
PPG
-1.510
(-1.38%)
107.550 USD
RPM
RPM
-1.390
(-1.28%)
107.400 USD
S
SEE
-0.540
(-1.72%)
30.880 USD
SHW
SHW
-4.82
(-1.44%)
330.96 USD
المزيد
الأخبار المقالات

العنوان: Rallybio Corp

القطاع: Healthcare
الصناعة: Biotechnology
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.